OTC Pharmaceuticals - Iceland

  • Iceland
  • Revenue in the OTC Pharmaceuticals market amounts to €95.00 in 2024. The market is expected to grow annually by 4.96% (CAGR 2024-2029).
  • The market's largest segment is the segment Other OTC Pharmaceuticals with a market volume of €52.96 in 2024.
  • In global comparison, most revenue is generated in the United States (€38,250 in 2024).
  • In relation to total population figures, per person revenues of €251.50 are generated in 2024.
  • In the OTC Pharmaceuticals market, 0.8% of total revenue will be generated through online sales by 2024.

Key regions: Worldwide, India, Philippines, United States, Europe

 
Mercado
 
Región
 
Comparación de regiones
 
Moneda
 

Analyst Opinion

The OTC Pharmaceuticals market in Iceland has been experiencing steady growth in recent years, driven by various factors such as customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. Customer preferences in Iceland have played a significant role in the development of the OTC Pharmaceuticals market.

Icelandic consumers have shown a growing preference for self-care and self-medication, leading to increased demand for over-the-counter medications. This trend can be attributed to factors such as convenience, accessibility, and cost-effectiveness. Consumers in Iceland are increasingly seeking quick and easy solutions for minor ailments and are willing to rely on OTC medications for relief.

Trends in the market have also contributed to the growth of the OTC Pharmaceuticals market in Iceland. The market has witnessed a shift towards natural and herbal remedies, as consumers become more conscious of the ingredients and potential side effects of traditional pharmaceutical products. This trend is in line with the global movement towards natural and holistic healthcare solutions.

As a result, there has been an increase in the availability and demand for OTC natural and herbal products in Iceland. Local special circumstances have further fueled the growth of the OTC Pharmaceuticals market in Iceland. The country's small population and limited healthcare infrastructure make OTC medications a practical and accessible option for many consumers.

The remote geography of Iceland also plays a role, as it can be challenging for individuals to access healthcare facilities in certain areas. This has led to a greater reliance on OTC medications for immediate relief and treatment. Underlying macroeconomic factors have also contributed to the development of the OTC Pharmaceuticals market in Iceland.

The country's stable economy and high disposable income levels have allowed consumers to afford OTC medications. Additionally, the government's focus on promoting self-care and reducing the burden on the healthcare system has created a favorable environment for the OTC Pharmaceuticals market to thrive. In conclusion, the OTC Pharmaceuticals market in Iceland is growing steadily due to customer preferences for self-care, trends in the market towards natural and herbal remedies, local special circumstances such as limited healthcare infrastructure, and underlying macroeconomic factors such as a stable economy and high disposable income levels.

These factors collectively contribute to the increasing demand for OTC medications in Iceland.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Visión general

  • Revenue
  • Key Players
  • Analyst Opinion
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Espere, por favor

Contacto

¿Alguna duda? Estaremos encantados de atenderte.
Statista Locations
Contacto Nerea Marcos
Nerea Marcos
Client Success Manager

Lu - vi, 9:30 - 17:00 h (CET)

Contacto Meredith Alda
Meredith Alda
Sales Manager– Contacto (Estados Unidos)

Lu - vi, 9:00 - 18:00 h (EST)

Contacto Yolanda Mega
Yolanda Mega
Operations Manager– Contacto (Asia)

Lu - vi, 9:00 - 17:00 h (SGT)

Contacto Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contacto (Asia)

Lu - vi, 10:00 - 18:00 h (JST)

Contacto Lodovica Biagi
Lodovica Biagi
Director of Operations– Contacto (Europa)

Lu - vi, 9:30 - 17:00 h (GMT)

Contacto Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contacto (América Latina)

Lu - vi, 9:00am-6:00pm (EST)